Cumberland Pharmaceuticals Inc.
CPIX
$6.29
-$0.33-4.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.86M | 11.01M | 11.44M | 15.20M | 16.09M |
| Total Receivables | 13.42M | 14.26M | 16.94M | 10.43M | 10.32M |
| Inventory | 29.90K | 5.45M | 6.23M | 2.93M | 3.22M |
| Prepaid Expenses | 676.00K | 2.07M | 2.45M | 1.38M | 1.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.65M | -- | -- | -- | -- |
| Total Current Assets | 33.64M | 32.79M | 37.06M | 29.94M | 31.21M |
|
|
|||||
| Total Current Assets | 33.64M | 32.79M | 37.06M | 29.94M | 31.21M |
| Net Property, Plant & Equipment | 7.53M | 7.86M | 8.61M | 7.86M | 7.42M |
| Long-term Investments | -- | 914.00K | 914.00K | 914.00K | 914.00K |
| Goodwill | -- | 914.00K | 914.00K | 914.00K | 914.00K |
| Total Other Intangibles | 43.80K | 12.79M | 14.03M | 15.01M | 15.99M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.66M | 12.80M | 12.23M | 12.17M | 12.38M |
| Total Assets | 62.88M | 71.00M | 76.82M | 65.90M | 67.91M |
|
|
|||||
| Total Accounts Payable | 19.55M | 16.54M | 18.57M | 13.83M | 13.45M |
| Total Accrued Expenses | 7.52M | -- | 10.03M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 503.00K | 485.20K | 467.80K | 401.40K | 386.10K |
| Total Finance Division Other Current Liabilities | 7.62M | 17.47M | 7.68M | 10.08M | 10.14M |
| Total Other Current Liabilities | 7.62M | 17.47M | 7.68M | 10.08M | 10.14M |
| Total Current Liabilities | 35.19M | 34.49M | 36.74M | 24.31M | 23.97M |
|
|
|||||
| Total Current Liabilities | 35.19M | 34.49M | 36.74M | 24.31M | 23.97M |
| Long-Term Debt | -- | 5.24M | 5.24M | 5.24M | 5.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.21M | 4.34M | 4.47M | 4.60M | 4.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.37M | 5.62M | 5.82M | 5.95M | 6.30M |
| Total Liabilities | 45.77M | 49.69M | 52.28M | 40.10M | 40.23M |
|
|
|||||
| Common Stock & APIC | 51.81M | 51.73M | 51.68M | 51.51M | 51.44M |
| Retained Earnings | -34.37M | -30.09M | -26.80M | -25.39M | -23.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 17.44M | 21.64M | 24.88M | 26.12M | 27.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.44M | 21.64M | 24.88M | 26.12M | 27.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -331.60K | -333.50K | -336.10K | -319.20K | -310.90K |
| Total Equity | 17.11M | 21.30M | 24.54M | 25.80M | 27.68M |
|
|
|||||